Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-11-005517
Filing Date
2011-08-05
Accepted
2011-08-05 13:05:30
Documents
11
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q ather_10q-063011.htm 10-Q 778605
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 17611
3 EXHIBIT 31.2 ex31-2.htm EX-31.2 17350
4 EXHIBIT 32.1 ex32-1.htm EX-32.1 6279
5 EXHIBIT 32.2 ex32-2.htm EX-32.2 6587
  Complete submission text file 0001437749-11-005517.txt   2785035

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE ahro-20110630.xml EX-101.INS 406840
7 XBRL TAXONOMY EXTENSION SCHEMA ahro-20110630.xsd EX-101.SCH 14398
8 XBRL TAXONOMY EXTENSION CALCULATION ahro-20110630_cal.xml EX-101.CAL 23351
9 XBRL TAXONOMY EXTENSION DEFINITION ahro-20110630_def.xml EX-101.DEF 74673
10 XBRL TAXONOMY EXTENSION LABELS ahro-20110630_lab.xml EX-101.LAB 106605
11 XBRL TAXONOMY EXTENSION PRESENTATION ahro-20110630_pre.xml EX-101.PRE 85909
Mailing Address 2301 DUPONT DRIVE, SUITE 525 IRVINE CA 92612
Business Address 2301 DUPONT DRIVE, SUITE 525 IRVINE CA 92612 (949) 525-5471
AtheroNova Inc. (Filer) CIK: 0001377053 (see all company filings)

EIN.: 201915083 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52315 | Film No.: 111013386
SIC: 2834 Pharmaceutical Preparations